| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.05 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |